APO-DEFERASIROX (TYPE J) 180 MG
DEFERASIROX : 180 MG · DIN 02485273 · APOTEX INC
Health Canada status: MARKETED
What is APO-DEFERASIROX (TYPE J)?
APO-DEFERASIROX (TYPE J) 180 MG contains DEFERASIROX : 180 MG. It is listed in the Health Canada Drug Product Database under DIN 02485273, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 29-May-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-DEFERASIROX (TYPE J) used for?
APO-DEFERASIROX (TYPE J) is indicated for the management of chronic iron overload in patients with transfusion-dependent anemias aged 6 years or older, the management of chronic iron overload in patients with transfusion-dependent anemias aged two to five who cannot be adequately treated with deferoxamine, and the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02485273 |
|---|---|
| Brand name | APO-DEFERASIROX (TYPE J) |
| Generic / active ingredient | DEFERASIROX : 180 MG |
| Manufacturer | APOTEX INC |
| Strength | 180 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | V03AC03 DEFERASIROX |
| AHFS class | 64:00.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 29-May-2019 |
| Original market date | 2019-05-29 00:00:00 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code V03AC03 DEFERASIROX. 36 of 45 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-DEFERASIROX | 125 MG | TABLET FOR SUSPENSION | APOTEX INC | MARKETED | DIN 02461544 |
| APO-DEFERASIROX | 250 MG | TABLET FOR SUSPENSION | APOTEX INC | MARKETED | DIN 02461552 |
| APO-DEFERASIROX | 500 MG | TABLET FOR SUSPENSION | APOTEX INC | MARKETED | DIN 02461560 |
| APO-DEFERASIROX (TYPE J) | 360 MG | TABLET | APOTEX INC | MARKETED | DIN 02485281 |
| APO-DEFERASIROX (TYPE J) | 90 MG | TABLET | APOTEX INC | MARKETED | DIN 02485265 |
| AURO-DEFERASIROX (TYPE J) | 180 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02527782 |
| AURO-DEFERASIROX (TYPE J) | 360 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02527790 |
| AURO-DEFERASIROX (TYPE J) | 90 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02527774 |
| EXJADE | 125 MG | TABLET FOR SUSPENSION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | DIN 02287420 |
| EXJADE | 250 MG | TABLET FOR SUSPENSION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED | DIN 02287439 |
Who else supplies DEFERASIROX worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DEFERASIROX appears in 1125 registered pack listings across 15 markets, published on 12 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.